Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76dc6f46d01377e60b8a63914234f3c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec974e7e3c61ade7bda39dee1c133a05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_482814d052533acc80acbaca5d398d64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b68ae9c2076a39b8716dfe9b1db626eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52198e17a8a879cd22c6684bc085b27c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c98638db9185f632d4d226d9d2fafb63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55f8d67368dfbaae99052754f649f006 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5585 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
filingDate |
2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a3bd58a8bb1c58bcd4541e05cf70273 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89f1ee9c5dfe609617e75239fee7eaee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d167b356baac8a241635742590669a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f94284f8a64ba604dc1e7e99e275d5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_202ff67dbe77181a39b8a8a7cc0311b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3681ce2041709f65dae4cab2ffc7aacf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77bcc4210b19bbd67aa460ae7ac2a42e |
publicationDate |
2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012128496-A2 |
titleOfInvention |
Pharmaceutical composition for preventing or treating asthma containing maackiain as an active ingredient |
abstract |
The present invention relates to a pharmaceutical composition for preventing or treating asthma containing maackiain as an active ingredient. The maackiain of the present invention can be used to advantage as a composition for preventing, treating and alleviating asthma because it has an outstanding effect in suppressing the production of ovalbumin and in particular IgE in serum and bronchoalveolar lavage fluid and in suppressing the expression of Th2 cytokines in the lungs, in addition to suppressing the volume of active oxygen created in the respiratory tract and suppressing the infiltration of inflammatory cells into the bronchi and relieving respiratory-tract hypersensitivity which constitute problems that cause asthma in in-vivo studies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101295079-B1 |
priorityDate |
2011-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |